Liposomes and liposome-like nanoparticles: From anti-fungal infection to the COVID-19 pandemic treatment

The liposome is the first nanomedicine transformed into the market and applied to human patients. Since then, such phospholipid bilayer vesicles have undergone technological advancements in delivering small molecular-weight compounds and biological drugs. Numerous investigations about liposome uses...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Yonglong, Zhang, Wanting, Xiao, Qingqing, Fan, Lifang, Huang, Dechun, Chen, Wei, He, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shenyang Pharmaceutical University 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671608/
https://www.ncbi.nlm.nih.gov/pubmed/36415834
http://dx.doi.org/10.1016/j.ajps.2022.11.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671608/
https://www.ncbi.nlm.nih.gov/pubmed/36415834
http://dx.doi.org/10.1016/j.ajps.2022.11.002

Ejemplares similares